Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Dhundass

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
American Journal of Ophthalmology|October 12, 2018
Predictive Factors of Response to Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous ChorioretinopathyElodie Bousquet, Myriam Dhundass, Raphaël Lejoyeux, et al.
Retina (Philadelphia, Pa.)|January 22, 2019
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSIONSophie Bonnin, Bénédicte Dupas, Carlo Lavia, et al.
American Journal of Ophthalmology|February 27, 2016
Shift Work: A Risk Factor for Central Serous ChorioretinopathyElodie Bousquet, Myriam Dhundass, Mathieu Lehmann, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
American Journal of Ophthalmology|October 12, 2018
Predictive Factors of Response to Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous ChorioretinopathyElodie Bousquet, Myriam Dhundass, Raphaël Lejoyeux, et al.
Retina (Philadelphia, Pa.)|January 22, 2019
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSIONSophie Bonnin, Bénédicte Dupas, Carlo Lavia, et al.
American Journal of Ophthalmology|February 27, 2016
Shift Work: A Risk Factor for Central Serous ChorioretinopathyElodie Bousquet, Myriam Dhundass, Mathieu Lehmann, et al.
Pageof 1